Tue. Sep 29th, 2020

Fxtriangle | Market analysis | Managed trading

Fxtriangle will make Fx trading look easy.

Glenmark Pharma rises 4% after Favipiravir shows encouraging results in Phase 3 trial

1 min read

Glenmark Pharmaceuticals rose as much as 4.06% on Thursday after the company announced top-line results from phase 3 clinical trial of favipiravir in patients with mild to moderate covid-19 symptoms.

At 1:08 pm, shares of Glenmark Pharmaceuticals were trading at 421.95 apiece on BSE, up 2% from its previous close, while the benchmark Sensex advanced 0.5% to 38,061.27 point.

The drug maker on Wednesday announced top-line results from a Phase 3 clinical trial in mild to moderate covid-19 patients conducted across seven clinical sites in India.

The open-label randomised, multicenter clinical trial, conducted in 150 patients, evaluated the efficacy and safety of Favipiravir plus standard supportive care (Favipiravir treatment arm), versus standard supportive care alone (control arm), in the patients, randomized within a 48 hour window of testing RT-PCR positive for covid-19.

Results from the Phase 3 trail showed numerical improvements for the primary efficacy endpoint with 28.6% faster viral clearance in the overall population as measured by the median time until cessation of oral shedding of virus in the Favipiravir treatment arm compared to those in the control arm.

Glenmark has received manufacturing and marketing approval from India’s drug regulator for FabiFlu, making it the first approved oral medication in India for the treatment of mild to moderate covid-19 patients.

Leave a Reply

Forex trading and any instruments related to Foreign Exchange Market are Speculative and carry substantial risk of loss of either partial equity or the entire deposit amount. Leverage adds up to the risk, before considering to invest in this venture, you should first consider your financial position and may seek the help of an independent financial advisor. FXtriangle dis-recommends the usage of loan instruments to trade in this market as it can hamper financial position. Please do not invest the money that you cannot afford to lose. FXtriangle provides all its services throughout the Globe Excluding (Nigeria, British Virgin Island & the Islamic Republic of Iran) and also provides limited service in some jurisdictions where investment in Overseas markets / Fx Exchanges are prohibited by Law If you are not sure to contact us before using any of our services. FXtriangle acts as an Independent Corporate Financial Advisor and connects you to various overseas exchanges and cannot be held liable for any financial damage occurring through their side. All of our partnered institutions are regulated in various jurisdictions.FXtriangle conducts an independent background check before partnering with any institutions to fulfill your investment objectives smoothly. The usage of our Business name, Logo or any trademark in any financial forum, website, review website, complaint arena, Billboards without our written permission will attract lawsuits.